3 Comments
 

Based on the most helpful WSO content, the PWP Healthcare (HC) team is known for having strong deal flow, particularly in devices and life sciences. However, it has been noted that their presence in biopharma is not as strong compared to other elite boutiques like Evercore, Lazard, or CVP. The deal experience in HC at PWP is therefore somewhat different from those firms.

In terms of culture, the HC team is described as "insanely sweaty," with a rough culture overall. While the deal flow remains robust, the demanding nature of the group and the challenging work environment are consistent themes. There is no specific mention of improvements in culture as of 2026, so it seems the team continues to be intense and high-pressure.

Sources: PWP NY Groups, PWP LA, Lazard LA, and Houlihan LA (RX), PWP RX culture/exits, PWP LA vs Lazard LA

I'm an AI bot trained on the most helpful WSO content across 17+ years.
 

Medtech they’re very good, arguably top overall, but beyond that not great (trash). I’d rank them below CVP/JPM/GS/EVR but they are very lean so as an analyst your experience is likely very good (sweaty).

They closed Shockwave and Penumbra, two of the largest sell sides in the space, and have done many other name brand transactions there as well. Huge key man risk though as they’re basically all done by one partner.

 

Autem tempora aut consequuntur laborum ipsum quas et. Aliquam sit nihil est nemo similique. Aspernatur repellendus et exercitationem ut qui.

Autem iure molestiae accusamus quia dolorum expedita repellat. Quisquam dolor vero ipsam est. Distinctio sed possimus neque sunt cumque aut. Et et reprehenderit voluptatem. Excepturi ratione voluptatibus dolores quidem sunt optio dignissimos eos. Porro ut quisquam sequi aut.

Career Advancement Opportunities

October 2026 Investment Banking

  • Evercore 01 99.5%
  • Moelis & Company 01 99.0%
  • JPMorgan 01 98.4%
  • Guggenheim Partners 02 97.9%
  • Morgan Stanley 06 97.4%

Overall Employee Satisfaction

October 2026 Investment Banking

  • Moelis & Company No 99.5%
  • Morgan Stanley 02 99.0%
  • Evercore 01 98.4%
  • Banco Santander 02 97.9%
  • BMO Capital Markets 12 97.4%

Professional Growth Opportunities

October 2026 Investment Banking

  • Evercore 01 99.5%
  • Moelis & Company 01 99.0%
  • Morgan Stanley 05 98.4%
  • Goldman Sachs 01 97.9%
  • JPMorgan No 97.4%

Total Avg Compensation

October 2026 Investment Banking

  • Vice President (16) $429
  • Associates (57) $264
  • 3rd+ Year Analyst (8) $210
  • 2nd Year Analyst (28) $184
  • Intern/Summer Associate (16) $161
  • 1st Year Analyst (84) $151
  • Intern/Summer Analyst (76) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

1
redever's picture
redever
99.2
2
BankonBanking's picture
BankonBanking
99.0
3
kanon's picture
kanon
99.0
4
Secyh62's picture
Secyh62
99.0
5
Betsy Massar's picture
Betsy Massar
98.9
6
CompBanker's picture
CompBanker
98.9
7
GameTheory's picture
GameTheory
98.9
8
dosk17's picture
dosk17
98.9
9
DrApeman's picture
DrApeman
98.9
10
Mimbs's picture
Mimbs
98.8
success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”